BioMedTracker is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Informa

Search

Drug Impact Events

Date Lead
Company
Event Type Approval
Change
Approval
Likelihood
8/27/16 GlaxoSmithKline (GSK) Zanamivir for Influenza therapeutics (excluding vaccines) Subscribers Only Subscribers Only Subscribers Only
8/25/16 Mallinckrodt (MNK) Synacthen Depot for Muscular Dystrophy Subscribers Only Subscribers Only Subscribers Only
8/25/16 Galectin Therapeutics (GALT) GR-MD-02 for Psoriasis Subscribers Only Subscribers Only Subscribers Only
8/25/16 Mylan (MYL) Biosimilar Trastuzumab (Mylan) for Breast Cancer Subscribers Only Subscribers Only Subscribers Only
8/25/16 Novartis (NVS) BAF312 for Multiple Sclerosis (MS) Subscribers Only Subscribers Only Subscribers Only

Upcoming Catalysts

Expected
Date Range
Lead
Company
Drug Expected
Catalyst
08/27/16 Subscribers Only Subscribers Only Trial Data - Updated Results
08/28/16 Subscribers Only Subscribers Only Patent - Expiration
08/28/16 Subscribers Only Subscribers Only Patent - Expiration
08/28/16 Subscribers Only Subscribers Only Trial Data - Updated Results
08/28/16 Subscribers Only Subscribers Only Trial Data - Other